A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis
Clinical trial NCT05006352 · COMPLETED
Trial details
- NCT number
- NCT05006352
- Sponsor
- Denali Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-11
- Primary completion
- 2022-12-15
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.